Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter

Genes and Immunity

Volumn 2, Issue 2, 2001, Pages 105-109

  Hohjoh, H ^a   Tokunaga, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allele specific binding; Electrophoretic mobility shift assay (EMSA); OCT 1; Single nucleotide polymorphism (SNP); Tumor necrosis factor alpha (TNF )

Indexed keywords

DNA; DNA BINDING PROTEIN; HCFC1 PROTEIN, HUMAN; HOST CELL FACTOR C1; MONOCLONAL ANTIBODY; OCTAMER TRANSCRIPTION FACTOR 1; POU2F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CELL FRACTIONATION; CELL LINE; ELECTROPHORESIS; GENETICS; HAPLOTYPE; HUMAN; METABOLISM; METHODOLOGY; OLIGONUCLEOTIDE PROBE; PHYSIOLOGY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTIBODIES, MONOCLONAL; CELL FRACTIONATION; CELL LINE; DNA; DNA-BINDING PROTEINS; ELECTROPHORESIS; HAPLOTYPES; HOST CELL FACTOR C1; HUMANS; OCTAMER TRANSCRIPTION FACTOR-1; OLIGONUCLEOTIDE PROBES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035317243     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363721     Document Type: Article

References (21)

1. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction. Hum Mol Genet 1992; 1: 353.
2. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter. Immunogenetics 1994; 39: 150-154.
3. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998; 51: 605-612.
4. Uglialoro AM, Turbay D, Pesavento PA et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens 1998; 52: 359-367.
5. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effective of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
6. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
7. Skoog T, van't Hooft FM, Kallin B et al. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumor necrosis factor-α (TNF-α) gene associated with reduced circulating level of TNF-α. Hum Mol Genet 1999; 8: 1443-1449.
8. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511.
9. Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1364.
10. Fernandez-Real JM, Gutierrez C, Ricart W et al. The TNF-α gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997; 46: 1468-1472.
11. Herrmann SM, Ricard S, Nicaud V et al. Polymorphisms of the tumor necrosis factor-α gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28: 59-66.
12. Knight JC, Udalova I, Hill AVS et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
13. Hohjoh H, Nakayama T, Ohashi J et al. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-α) gene promoter with human narcolepsy. Tissue Antigens 1999; 54: 138-145.
14. Kamizono S, Yamada K, Seki N et al. Susceptible locus for obese type 2 diabetes mellitus in the 5′-flanking region for the tumor necrosis factor-alpha gene. Tissue Antigens 2000; 55: 449-452.
15. Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K. Independent contribution of HLA-DRB1 and TNFα promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun 2000; 1: 351-357.
16. Matsushita M, Tsuchiya N, Nakayama T et al. Allele typing of human TNFA 5′-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese. Tissue Antigens 1999; 54: 478-484.
17. Akiyama Y. TFSEARCH: Searching Transcription Factor Binding Sites, http://www.rwcp.or.jp/papia/
18. Heinemeyer T, Wingender E, Reuter I et al. Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucl Acids Res 1998; 26: 364-370.
19. Verrijzer C.P, Alkema MJ, van Weperen WW, Van Leeuwen HC, Strating MJJ, van der Vliet PC. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J 1992; 11: 4993-5003.
20. Tosato G. Generation of Epstein-Barr virus (EBV)-immortalized B cell line. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds). Current Protocols in Immunology. John Wiley & Sons: New York, 1991, pp 7.22.1-7.22.3.
21. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucl Acids Res 1989; 17: 6419.